跳到正文
原文
Endpoints News 生物医药· Anna Brown·· 17 天前AI 评分31

WuXi Biologics 和 Fresenius 达成大型生物类似药合作

WuXi Biologics, Fresenius partner ahead of biosimilar boom

AI 导读

WuXi Biologics 和德国制药商 Fresenius 近达成一项大型生物类似药合作协议,预示着生物类似药市场的蓬勃发展。

正文

WuXi Bi­o­log­ics and Ger­man drug­mak­er Fre­se­nius have reached one of the largest biosim­i­lar deals to date ahead of what some in the in­dus­try have called …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news